|
|
Article: Sinovac Biotech Ltd.: Update on Human Clinical Trials of SARS Vaccine; Additional 14 Volunteers Healthy After First Inoculation.
- Article from:
- Business Wire
- Article date:
- July 8, 2004
CopyrightCOPYRIGHT 2004 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
BEIJING -- Sinovac Biotech Ltd. ("Sinovac") (OTCBB:SNVBF) announced that the second subgroup of 14 volunteers in Phase 1 clinical trials of its SARS vaccine received their first inoculation two weeks ago and results of recent blood testing has shown that there are no adverse reactions reported to date. The inoculation process of the initial 4 volunteers as first reported on May 25th, 2004 has been completed. Those first 4 volunteers received their initial inoculation on May 22, 2004, and after no adverse side effects were observed, the volunteers received a second inoculation on 19 June 2004. Upon completion of the first 30-day observation period those recipients remain ...